Ray Y. Hachem

Ray Y. Hachem is a Professor at The University of Texas MD Anderson Cancer Center, where he specializes in infectious diseases, oncology, and clinical microbiology. His research focuses on antimicrobial resistance, hospital-acquired infections, and the antimicrobial elution profiles of central venous catheters, particularly their antibacterial and antifungal durability. He has led prospective randomized trials evaluating novel lock therapies, such as minocycline/EDTA/ethanol, for catheter-related bloodstream infections, and contributed to international consensus guidelines for cytomegalovirus management in leukemia patients. His recent work includes studies on dalbavancin for Staphylococcus aureus bacteremia, published in JAMA, and chronic wound care innovations in the International Wound Journal.